1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, SP; Athanasiou, A; Bagiokou, D; Bates, TE; Bradshaw, TD; Calabrese, V; Clarke, AB; Clothier, RH; Constantinescu, CS; Fang, L; Kendall, DA; Kumaran, NM; Lobo, DN; Loesch, A; Smith, PA; Turner, AE; Vakilpour, S; Westwell, AD | 1 |
1 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death.
Topics: Apoptosis; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoids; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dronabinol; Electron Transport Complex I; Electron Transport Complex II; Electron Transport Complex III; Endocannabinoids; Humans; Hydrogen Peroxide; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Models, Biological; Oxygen Consumption; Polyunsaturated Alkamides | 2007 |